You have 9 free searches left this month | for more free features.

oral cavity carcinoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alcohol-Related Carcinoma, Fanconi Anemia, Oral Cavity Carcinoma Trial in Minneapolis (Alcohol, Biospecimen Collection, Breath

Recruiting
  • Alcohol-Related Carcinoma
  • +2 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jul 25, 2023

Oral Cavity Squamous Cell Carcinoma Trial in San Francisco (NisinZ® P, Surgery (non-interventional, standard of care))

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • NisinZ® P
  • Surgery (non-interventional, standard of care)
  • San Francisco, California
    University of California, San Francisco
Oct 18, 2023

Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA

Withdrawn
  • Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
  • +6 more
  • hypofractionated radiation therapy
  • +3 more
  • New Brunswick, New Jersey
  • +1 more
Sep 27, 2022

Head and Neck Carcinoma, Malignant Parotid Gland Tumor, Maxillary Sinus Carcinoma Trial in United States (Best Practice, Medical

Recruiting
  • Head and Neck Carcinoma
  • +6 more
  • Best Practice
  • Medical Device Usage and Evaluation
  • Phoenix, Arizona
  • +3 more
Oct 10, 2022

Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

Not yet recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • +4 more
  • Near Infrared Imaging
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 5, 2022

Oral Cavity Squamous Cell Carcinoma Trial in Yichang (Sintilimab, Radiotherapy)

Recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • Yichang, Hubei, China
    Department of Medical Oncology, Central Hospital of Yichang City
Feb 18, 2023

Oral Squamous Cell Carcinoma, Maxillo-facial Surgery, Biomarkers Trial in Amiens (saliva tube)

Recruiting
  • Oral Squamous Cell Carcinoma
  • +5 more
  • saliva tube
  • Amiens, Picardie, France
    Amiens University Hospital
Mar 17, 2023

Erythroplakia, Leukoplakia, Oral Cavity Carcinoma Trial in Philadelphia (Metformin, Biopsy)

Recruiting
  • Erythroplakia
  • +3 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Sep 7, 2022

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA

Recruiting
  • Oral Cancer
  • +2 more
  • Biopsy Specimens Histopathology
  • Rawalpindi, Punjab, Pakistan
    Armed Forces Institute of Pathology
Jun 22, 2023

Squamous Cell Carcinoma of the Oral Cavity Trial in Rouen (Circulating tumor DNA detection)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • Circulating tumor DNA detection
  • Rouen, France
  • +1 more
Jun 29, 2023

Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Oral Cavity Squamous Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

Recruiting
  • Squamous Cell Carcinoma of Oral Cavity
  • +3 more
  • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
  • Gliwice, Silesia, Poland
    The Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023

Oral Cavity Squamous Cell Carcinoma Trial in Leuven (Durvalumab, Durvalumab + Tremelimumab)

Active, not recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • Leuven, Belgium
    UZ Leuven
May 30, 2022

Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous

Recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • Guangzhou, Guangdong, China
    Liuxiqiang
Feb 1, 2023

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Stage I Oral Cavity Squamous Cell Carcinoma, Stage II Oral Cavity Squamous Cell Carcinoma Trial in Buffalo, Rochester (drug,

Terminated
  • Stage I Oral Cavity Squamous Cell Carcinoma
  • Stage II Oral Cavity Squamous Cell Carcinoma
  • Buffalo, New York
  • +1 more
May 6, 2022

Head and Neck Carcinoma, Head and Neck Carcinoma of Unknown Primary, Hypopharyngeal Carcinoma Trial in Scottsdale, Rochester

Recruiting
  • Head and Neck Carcinoma
  • +10 more
  • Scottsdale, Arizona
  • +1 more
Jan 6, 2023

Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
  • Black Raspberry
  • (no location specified)
Oct 16, 2023

Articulatory Adaptation Following Oral Cancer Treatment

Recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • Speech Disorders
  • Electromagnetic Articulography
  • Groningen, Netherlands
  • +1 more
May 25, 2023

Oral Cavity Squamous Cell Carcinoma Trial in Mumbai (Sentinel node biopsy)

Recruiting
  • Oral Cavity Squamous Cell Carcinoma
  • Sentinel node biopsy
  • Mumbai, Maharashtra, India
    Tata Memorial Hospital
Jul 15, 2023

Oropharyngeal Dysplasia, Oral Cavity Dysplasia, Oral Carcinoma in Situ Trial in Miami (APG-157)

Not yet recruiting
  • Oropharyngeal Dysplasia
  • +2 more
  • Miami, Florida
    University of Miami
May 9, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Hangzhou, Zhejiang, China
    Department of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023

Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Jerusalem (Radiation: Diffusing Alpha Radiation Emitters

Not yet recruiting
  • Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT
  • Jerusalem, Israel
    Sharett institute, Hadassah University Hospital - Ein-Kerem
Jul 4, 2022